Principal Investigator
Peter Hosein
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240170
Clinical Trial Summary
LuMIERE: A Phase 1/2, Multicenter, Open-label, Non-randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
+1 (954) 8177628